Works matching AU Yasugi, Masayuki


Results: 12
    1

    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

    Published in:
    Clinical Lung Cancer, 2019, v. 20, n. 2, p. 134, doi. 10.1016/j.cllc.2018.10.008
    By:
    • Ninomiya, Takashi;
    • Ishikawa, Nobuhisa;
    • Inoue, Koji;
    • Kubo, Toshio;
    • Yasugi, Masayuki;
    • Shibayama, Takuo;
    • Maeda, Tadashi;
    • Fujitaka, Kazunori;
    • Kodani, Masahiro;
    • Yokoyama, Toshihide;
    • Kuyama, Shoichi;
    • Ochi, Nobuaki;
    • Ueda, Yutaka;
    • Miyoshi, Seigo;
    • Kozuki, Toshiyuki;
    • Amano, Yoshihiro;
    • Kubota, Tetsuya;
    • Sugimoto, Keisuke;
    • Bessho, Akihiro;
    • Ishii, Tomoya
    Publication type:
    Article
    2

    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.

    Published in:
    2018
    By:
    • Ninomiya, Takashi;
    • Ishikawa, Nobuhisa;
    • Inoue, Koji;
    • Kubo, Toshio;
    • Yasugi, Masayuki;
    • Shibayama, Takuo;
    • Maeda, Tadashi;
    • Fujitaka, Kazunori;
    • Kodani, Masahiro;
    • Yokoyama, Toshihide;
    • Kuyama, Shoichi;
    • Ochi, Nobuaki;
    • Ueda, Yutaka;
    • Miyoshi, Seigo;
    • Kozuki, Toshiyuki;
    • Amano, Yoshihiro;
    • Kubota, Tetsuya;
    • Sugimoto, Keisuke;
    • Bessho, Akihiro;
    • Ishii, Tomoya
    Publication type:
    journal article
    3

    Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1447, doi. 10.1093/jjco/hyaa152
    By:
    • Kubo, Toshio;
    • Watanabe, Hiromi;
    • Ninomiya, Kiichiro;
    • Kudo, Kenichiro;
    • Minami, Daisuke;
    • Murakami, Etsuko;
    • Ochi, Nobuaki;
    • Ninomiya, Takashi;
    • Harada, Daijiro;
    • Yasugi, Masayuki;
    • Ichihara, Eiki;
    • Ohashi, Kadoaki;
    • Rai, Kammei;
    • Fujiwara, Keiichi;
    • Hotta, Katsuyuki;
    • Tabata, Masahiro;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    4

    The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 762, doi. 10.1093/jjco/hyz066
    By:
    • Watanabe, Hiromi;
    • Kubo, Toshio;
    • Ninomiya, Kiichiro;
    • Kudo, Kenichiro;
    • Minami, Daisuke;
    • Murakami, Etsuko;
    • Ochi, Nobuaki;
    • Ninomiya, Takashi;
    • Harada, Daijiro;
    • Yasugi, Masayuki;
    • Ichihara, Eiki;
    • Ohashi, Kadoaki;
    • Fujiwara, Keiichi;
    • Hotta, Katsuyuki;
    • Tabata, Masahiro;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    5
    6
    7
    8

    A New Human Lung Adenocarcinoma Cell Line Harboring the EML4-ALK Fusion Gene.

    Published in:
    Japanese Journal of Clinical Oncology, 2014, v. 44, n. 10, p. 963, doi. 10.1093/jjco/hyu110
    By:
    • Isozaki, Hideko;
    • Yasugi, Masayuki;
    • Takigawa, Nagio;
    • Hotta, Katsuyuki;
    • Ichihara, Eiki;
    • Taniguchi, Akihiko;
    • Toyooka, Shinichi;
    • Hashida, Shinsuke;
    • Sendo, Toshiaki;
    • Tanimoto, Mitsune;
    • Kiura, Katsuyuki
    Publication type:
    Article
    9
    10

    A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 4, p. 250, doi. 10.1111/ajco.13147
    By:
    • Harada, Daijiro;
    • Kozuki, Toshiyuki;
    • Nogami, Naoyuki;
    • Bessho, Akihiro;
    • Hosokawa, Shinobu;
    • Fukamatsu, Nobuaki;
    • Hotta, Katsuyuki;
    • Ohashi, Kadoaki;
    • Kubo, Toshio;
    • Yoshioka, Hiroshige;
    • Yokoyama, Toshihide;
    • Sone, Naoyuki;
    • Kuyama, Shoichi;
    • Kudo, Kenichiro;
    • Yasugi, Masayuki;
    • Takigawa, Nagio;
    • Oze, Isao;
    • Kiura, Katsuyuki
    Publication type:
    Article
    11

    A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5237, doi. 10.1007/s00520-021-06092-1
    By:
    • Ninomiya, Kiichiro;
    • Yokoyama, Toshihide;
    • Hotta, Katsuyuki;
    • Oze, Isao;
    • Katsui, Kuniaki;
    • Hata, Tae;
    • Yoshioka, Hiroshige;
    • Bessho, Akihiro;
    • Hosokawa, Shinobu;
    • Kuyama, Shoichi;
    • Kudo, Kenichiro;
    • Kozuki, Toshiyuki;
    • Harada, Daijiro;
    • Yasugi, Masayuki;
    • Murakami, Toshi;
    • Nakanishi, Masamoto;
    • Takigawa, Nagio;
    • Maeda, Yoshinobu;
    • Kiura, Katsuyuki
    Publication type:
    Article
    12